Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-CD19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06222853
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06590545
What this trial is testing

Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis

Who this might be right for
ANCA-IgG-positive ANCA Associated Vasculitis
David Simon 8
Early research (Phase 1)UnknownNCT05270772
What this trial is testing

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

Who this might be right for
CD19+ Relapse/Refractory B-ALL
Chinese PLA General Hospital 9
Early research (Phase 1)UnknownNCT04194931
What this trial is testing

Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
The First Affiliated Hospital of Nanchang University 20
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Not applicableLooking for participantsNCT07120633
What this trial is testing

Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL

Who this might be right for
CLLCAR-T Cell TherapySLL
The Affiliated Hospital of Xuzhou Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Early research (Phase 1)Study completedNCT00274742
What this trial is testing

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Who this might be right for
Non-Hodgkin's Lymphoma, Relapsed
Amgen Research (Munich) GmbH 76
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Not applicableApproved For MarketingNCT04300803
What this trial is testing

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

Who this might be right for
DLBCL
MorphoSys AG
Early research (Phase 1)UnknownNCT04637763
What this trial is testing

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Non Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+4 more
Caribou Biosciences, Inc. 72
Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Large-scale testing (Phase 3)UnknownNCT05020392
What this trial is testing

Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaBurkitt LymphomaFollicular Lymphoma+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Not applicableLooking for participantsNCT07121777
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Anhui Provincial Hospital 18
Not applicableLooking for participantsNCT07472972
What this trial is testing

Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

Who this might be right for
LymphomaLymphoid Hematological Malignancies
University of Zurich 50
Early research (Phase 1)Looking for participantsNCT06138132
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Stanford University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06733935
What this trial is testing

NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesAntineutrophil Cytoplasmic Antibody-Associated Vasculitis+1 more
Nkarta, Inc. 240
Early research (Phase 1)Study completedNCT03939026
What this trial is testing

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma
Allogene Therapeutics 50
Testing effectiveness (Phase 2)Looking for participantsNCT07549698
What this trial is testing

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

Who this might be right for
Warm Autoimmune Hemolytic Anemia (WAIHA)ITP - Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
CRISPR Therapeutics AG 60
Testing effectiveness (Phase 2)Looking for participantsNCT05334823
What this trial is testing

PCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Who this might be right for
Acute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 100
Next Page